ESTUTC-5 New YorkLog in Sign up

ACTU
Actuate Therapeutics, Inc. Common stock
stockNASDAQ

Market OpenNov 13, 2026 12:55:33 PM EST

0.30USD+1.284%(+0.00)92,517

Pre-marketNov 13, 2026 9:28:30 AM EST

0.3064USD+3.514%(+0.0104)

0.2500Bid0.3100Ask0.0700Spread

Loading…

Loading…

7.14M

Previous Close

$0.30

Beta

1.75

52-Week High

$7.90 2025-12-10

52-Week Low

$0.29 2026-11-12

SMA 50

$0.69

SMA 200

$1.93

Avg. Vol 10D

316,918

Avg. Vol 30D

461,671

Avg. Vol 90D

418,298

Relative Vol

0.19

24.01M

8.46M

35.24%

1,298,553

Short Interest %

15.09%

2.12

On/Off Exchange

45%/55%

49.13%

Short Vol % (off-exch)

42.09%

14.0900%

4,000,000

9,336

26,198

95,859

Net Income (TTM)

-20.5M

Return on Equity %

2,457.58

Nov 4, 2026

08:00 AM ESTActuate Therapeutics to Present Promising Preclinical Data Demonstrating Antitumor and Immune Activation Activity of Elraglusib Oral Tablet in Advanced Melanoma Models at ENA 2026 ·

GlobeNewswire Inc.

Nov 2, 2026

08:50 AM ESTActuate Therapeutics (ACTU) Secures USPTO Notice of Allowance for Oral Elraglusib Patent ·

GuruFocus

08:00 AM ESTActuate Therapeutics Receives U.S. Notice of Allowance for Patent Covering Elraglusib Oral Tablets ·

GlobeNewswire Inc.

Nov 1, 2026

01:31 AM ESTActuate Therapeutics CEO Daniel Schmitt purchases $49,999 in stock ·

Investing.com

Oct 27, 2026

08:18 AM EDTActuate Therapeutics prices $11M public offering of stock and warrants ·

Seeking Alpha

ACTU Performance

Period	Price	Date	Change	Beta
1W	0.33	2026-11-06	-9.58%	0.314
1M	0.47	2026-10-13	-36.24%	1.545
3M	0.98	2026-08-13	-69.51%	0.953
6M	2.97	2026-05-13	-89.99%	0.760
1Y	5.88	2025-11-13	-94.94%	1.752
2Y	8.56	2024-11-13	-96.53%	—

ACTU Stock Summary

Actuate Therapeutics, Inc. Common stock (NASDAQ:ACTU) stock price today is $0.30, and today's volume is 89,931. ACTU is up 0.439% today. The 30 day average volume is 461,671. ACTU market cap is $7.14M with 24.01M shares outstanding.